Mereo BioPharma Group (LTS:0A9G) Other Long Term Assets : $-0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mereo BioPharma Group Other Long Term Assets?

Mereo BioPharma Group's other long-term assets for the quarter that ended in Dec. 2024 was $-0.00 Mil.

Mereo BioPharma Group's quarterly other long-term assets declined from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($-0.00 Mil) but then stayed the same from Sep. 2024 ($-0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Mereo BioPharma Group's annual other long-term assets increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($-0.00 Mil) but then declined from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Mereo BioPharma Group Other Long Term Assets Historical Data

The historical data trend for Mereo BioPharma Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Other Long Term Assets Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

Mereo BioPharma Group Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

Mereo BioPharma Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Mereo BioPharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (LTS:0A9G) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

MREO:USA MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group Headlines

No Headlines